Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001564590-19-036493
Filing Date
2019-10-04
Accepted
2019-10-04 16:11:06
Documents
12
Period of Report
2019-08-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A dvax-8ka_20190812.htm   iXBRL 8-K/A 31213
  Complete submission text file 0001564590-19-036493.txt   164919

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dvax-20190812.xsd EX-101.SCH 5969
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20190812_lab.xml EX-101.LAB 20217
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20190812_pre.xml EX-101.PRE 12074
9 EXTRACTED XBRL INSTANCE DOCUMENT dvax-8ka_20190812_htm.xml XML 3969
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-34207 | Film No.: 191138728
SIC: 2834 Pharmaceutical Preparations